Akebia Therapeutics, Inc. - Common Stock (AKBA)
CUSIP: 00972D105
Q4 2025 13F Holders as of 31 Dec 2025
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 263,222,327
- Total 13F shares
- 118,251,483
- Share change
- -5,283,880
- Total reported value
- $190,384,320
- Put/Call ratio
- 110%
- Price per share
- $1.61
- Number of holders
- 165
- Value change
- -$16,095,281
- Number of buys
- 85
- Number of sells
- 79
Quarterly Holders Quick Answers
What is CUSIP 00972D105?
CUSIP 00972D105 identifies AKBA - Akebia Therapeutics, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 00972D105:
Top shareholders of AKBA - Akebia Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BlackRock, Inc. |
13F
13D/G
|
Company |
7.2%
from 13D/G
|
18,797,058
|
$51,315,969 | — | 30 Sep 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
5.9%
|
15,547,508
|
$42,444,697 | — | 30 Sep 2025 | |
| STATE STREET CORP |
13F
13D/G
|
Company · STATE STREET CORPORATION |
5.2%
from 13D/G
|
11,844,769
|
$32,336,219 | — | 30 Sep 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2.3%
|
6,184,951
|
$16,886,900 | — | 30 Sep 2025 | |
| Muneer A. Satter |
13D/G
|
Satter Muneer A |
2.6%
|
5,747,906
|
$13,105,226 | $0 | 31 Dec 2024 | |
| MORGAN STANLEY |
13F
|
Company |
1.6%
|
4,315,201
|
$11,780,499 | — | 30 Sep 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
1.5%
|
3,952,727
|
$10,790,945 | — | 30 Sep 2025 | |
| UBS Group AG |
13F
|
Company |
1.4%
|
3,646,233
|
$9,954,217 | — | 30 Sep 2025 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
1.2%
|
3,206,184
|
$8,752,882 | — | 30 Sep 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
1.2%
|
3,185,826
|
$8,697,305 | — | 30 Sep 2025 | |
| MPM BioImpact LLC |
13F
|
Company |
1.1%
|
2,889,125
|
$7,887,311 | — | 30 Sep 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
1.1%
|
2,857,237
|
$7,800,257 | — | 30 Sep 2025 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
1%
|
2,680,188
|
$7,316,914 | — | 30 Sep 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.94%
|
2,486,535
|
$6,788,241 | — | 30 Sep 2025 | |
| Affinity Asset Advisors, LLC |
13F
|
Company |
0.93%
|
2,450,000
|
$6,688,500 | — | 30 Sep 2025 | |
| Invesco Ltd. |
13F
|
Company |
0.91%
|
2,400,757
|
$6,554,067 | — | 30 Sep 2025 | |
| Nuveen, LLC |
13F
|
Company |
0.87%
|
2,301,377
|
$6,282,760 | — | 30 Sep 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.82%
|
2,170,281
|
$5,924,867 | — | 30 Sep 2025 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
0.82%
|
2,147,951
|
$5,862,000 | — | 30 Sep 2025 | |
| Nantahala Capital Management, LLC |
13F
|
Company |
0.76%
|
2,000,000
|
$5,460,000 | — | 30 Sep 2025 | |
| CITIGROUP INC |
13F
|
Company |
0.73%
|
1,916,692
|
$5,232,569 | — | 30 Sep 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.68%
|
1,788,500
|
$4,882,605 | — | 30 Sep 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.67%
|
1,767,813
|
$4,826,130 | — | 30 Sep 2025 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.67%
|
1,766,691
|
$4,822,671 | — | 30 Sep 2025 | |
| BARCLAYS PLC |
13F
|
Company |
0.45%
|
1,180,233
|
$3,222,037 | — | 30 Sep 2025 | |
| Connor, Clark & Lunn Investment Management Ltd. |
13F
|
Company |
0.39%
|
1,020,668
|
$2,786,424 | — | 30 Sep 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.38%
|
994,181
|
$2,714,114 | — | 30 Sep 2025 | |
| FMR LLC |
13F
|
Company |
0.35%
|
911,821
|
$2,489,272 | — | 30 Sep 2025 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
0.33%
|
869,804
|
$2,374,565 | — | 30 Sep 2025 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0.33%
|
858,541
|
$2,343,817 | — | 30 Sep 2025 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.3%
|
778,529
|
$2,125,384 | — | 30 Sep 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.26%
|
679,242
|
$1,854,330 | — | 30 Sep 2025 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
0.25%
|
662,530
|
$1,808,707 | — | 30 Sep 2025 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
0.24%
|
639,372
|
$1,745,485 | — | 30 Sep 2025 | |
| Swiss National Bank |
13F
|
Company |
0.19%
|
509,300
|
$1,390,389 | — | 30 Sep 2025 | |
| Aquatic Capital Management LLC |
13F
|
Company |
0.19%
|
506,909
|
$1,383,862 | — | 30 Sep 2025 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.19%
|
492,334
|
$1,344,071 | — | 30 Sep 2025 | |
| Rafferty Asset Management, LLC |
13F
|
Company |
0.18%
|
481,869
|
$1,315,502 | — | 30 Sep 2025 | |
| AQR CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.17%
|
442,472
|
$1,207,949 | — | 30 Sep 2025 | |
| Assenagon Asset Management S.A. |
13F
|
Company |
0.16%
|
426,766
|
$1,165,071 | — | 30 Sep 2025 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.14%
|
358,671
|
$979,162 | — | 30 Sep 2025 | |
| Jump Financial, LLC |
13F
|
Company |
0.14%
|
355,843
|
$971,452 | — | 30 Sep 2025 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
0.13%
|
349,280
|
$953,534 | — | 30 Sep 2025 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.12%
|
326,959
|
$892,598 | — | 30 Sep 2025 | |
| Ellen Snow |
3/4/5
|
SVP, CFO and Treasurer |
—
mixed-class rows
|
743,300
mixed-class rows
|
$872,424 | — | 31 Jan 2024 | |
| Michel Dahan |
3/4/5
|
SVP, Chief Operating Officer |
—
mixed-class rows
|
896,092
mixed-class rows
|
$846,836 | — | 13 May 2024 | |
| Nicole R. Hadas |
3/4/5
|
SVP, Chief Legal Officer |
—
mixed-class rows
|
875,243
mixed-class rows
|
$820,566 | — | 13 May 2024 | |
| VICTORY CAPITAL MANAGEMENT INC |
13F
|
Company |
0.11%
|
286,385
|
$781,831 | — | 30 Sep 2025 | |
| Creative Planning |
13F
|
Company |
0.11%
|
282,495
|
$771,211 | — | 30 Sep 2025 | |
| PRUDENTIAL FINANCIAL INC |
13F
|
Company |
0.11%
|
280,558
|
$765,923 | — | 30 Sep 2025 |
Institutional Holders of Akebia Therapeutics, Inc. - Common Stock (AKBA) as of Q4 2025
As of 31 Dec 2025,
Akebia Therapeutics, Inc. - Common Stock (AKBA) was held by
165 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
118,251,483 shares.
The largest 10 holders included
BlackRock, Inc., VANGUARD GROUP INC, STATE STREET CORP, GEODE CAPITAL MANAGEMENT, LLC, GOLDMAN SACHS GROUP INC, CITADEL ADVISORS LLC, RENAISSANCE TECHNOLOGIES LLC, Qube Research & Technologies Ltd, CITIGROUP INC, and NORTHERN TRUST CORP.
This page lists
165
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2025 vs Q3 2025 Across Filers
Q3 2025 holders
176
Q4 2025 holders
165
Holder diff
-11
| Investor | Q3 2025 Shares | Q4 2025 Shares | Share Diff | Share Chg % | Q3 2025 Value $ | Q4 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.